Additionally, mutations in the APP gene, which generally lead to an increase in Aβ peptide concentration, have been shown to cause some forms of early-onset familial AD, whereas mutations in tau genes without the presence of Aβ plaques can lead to non-Alzheimer dementias with neurofibrillary pathology [6]. The gene discussed is MAPT; the disease is Alzheimer disease.